V. Thiruvengadam, Carolin Sheril, Loyola Aumose, Mike Mwale, P. E. Mwale, Charles Chazemba, Marvecous Msuzi, Dumilani Njolomole, A. Beza, MemoryNkhata, Neema Thindwa, Sybil Kaduya, Faith, J. Nyirenda, Josophine Chinyama, E. Gama, ChrisyMsisya, Dhummie Kaunda, H. Moyo, Dennis Mdala, Connis Chisale
{"title":"中非马拉维共和国结核分枝杆菌现状报告(14.32′39.954′和35.11′26.269′)","authors":"V. Thiruvengadam, Carolin Sheril, Loyola Aumose, Mike Mwale, P. E. Mwale, Charles Chazemba, Marvecous Msuzi, Dumilani Njolomole, A. Beza, MemoryNkhata, Neema Thindwa, Sybil Kaduya, Faith, J. Nyirenda, Josophine Chinyama, E. Gama, ChrisyMsisya, Dhummie Kaunda, H. Moyo, Dennis Mdala, Connis Chisale","doi":"10.53555/eijbps.v5i1.30","DOIUrl":null,"url":null,"abstract":"Worldwide, Tuberculosis has one of the top ten causes of death and the leading cause from a distinct infectious agent (HIV/AIDS). In 2017, MTB has been affected and it was estimated 1.2 1.4 million (WHO, 2018). Globally MTB was estimated 10.0 million people have developed of ailments in 2017, for men 5.8 m and women 1.0 m children. In global they are different age group and overall 90% were adults (aged ≥ 15 years), 9% was affected and living with HIV (72% in Africa including Malawi) and two thirds were in eight countries: India (27%), China (9%), Indonesia (8%), the Philippines (6%), Pakistan (5%), Nigeria (4%), Bangladesh (4%) and South Africa (3%) (WHO, 2018).","PeriodicalId":257195,"journal":{"name":"EPH - International Journal of Biological & Pharmaceutical Science","volume":"25 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"STATUS REPORT OF MYCOBACTERIUM TUBERCULOSIS IN REPUBLIC OF MALAWI, CENTRAL AFRICA (14.32’39.954’S AND 35.11’26.269’E)\",\"authors\":\"V. Thiruvengadam, Carolin Sheril, Loyola Aumose, Mike Mwale, P. E. Mwale, Charles Chazemba, Marvecous Msuzi, Dumilani Njolomole, A. Beza, MemoryNkhata, Neema Thindwa, Sybil Kaduya, Faith, J. Nyirenda, Josophine Chinyama, E. Gama, ChrisyMsisya, Dhummie Kaunda, H. Moyo, Dennis Mdala, Connis Chisale\",\"doi\":\"10.53555/eijbps.v5i1.30\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Worldwide, Tuberculosis has one of the top ten causes of death and the leading cause from a distinct infectious agent (HIV/AIDS). In 2017, MTB has been affected and it was estimated 1.2 1.4 million (WHO, 2018). Globally MTB was estimated 10.0 million people have developed of ailments in 2017, for men 5.8 m and women 1.0 m children. In global they are different age group and overall 90% were adults (aged ≥ 15 years), 9% was affected and living with HIV (72% in Africa including Malawi) and two thirds were in eight countries: India (27%), China (9%), Indonesia (8%), the Philippines (6%), Pakistan (5%), Nigeria (4%), Bangladesh (4%) and South Africa (3%) (WHO, 2018).\",\"PeriodicalId\":257195,\"journal\":{\"name\":\"EPH - International Journal of Biological & Pharmaceutical Science\",\"volume\":\"25 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-08-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EPH - International Journal of Biological & Pharmaceutical Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.53555/eijbps.v5i1.30\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EPH - International Journal of Biological & Pharmaceutical Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53555/eijbps.v5i1.30","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
STATUS REPORT OF MYCOBACTERIUM TUBERCULOSIS IN REPUBLIC OF MALAWI, CENTRAL AFRICA (14.32’39.954’S AND 35.11’26.269’E)
Worldwide, Tuberculosis has one of the top ten causes of death and the leading cause from a distinct infectious agent (HIV/AIDS). In 2017, MTB has been affected and it was estimated 1.2 1.4 million (WHO, 2018). Globally MTB was estimated 10.0 million people have developed of ailments in 2017, for men 5.8 m and women 1.0 m children. In global they are different age group and overall 90% were adults (aged ≥ 15 years), 9% was affected and living with HIV (72% in Africa including Malawi) and two thirds were in eight countries: India (27%), China (9%), Indonesia (8%), the Philippines (6%), Pakistan (5%), Nigeria (4%), Bangladesh (4%) and South Africa (3%) (WHO, 2018).